2012-09-28T11:22:41-05:00 2011-12-31 453269313 YH ADVISORS INC 7755 CENTER AVENUE SUITE 1225 HUNTINGTON BEACH CA 92647 990 2011-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 WENDY SELIG 2023368935 2012-09-17 1 BRIAN YACKER P00401346 3109822806 2011 2016-02-24 21:20:13Z WENDY SELIG 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 21034891 0 X WWW.CUREMELANOMA.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 15 14 0 50 0 0 23589185 21013477 0 0 25642 21414 0 0 23614827 21034891 7856932 5103877 0 0 567410 710511 0 0 369544 765646 842050 9189988 6656438 14424839 14378453 16707780 31331243 104677 349687 16603103 30981556 X TO ACCELERATE THE PACE OF SCIENTIFIC DISCOVERY, ULTIMATELY TO FIND A CURE BY FUNDING THE MOST PROMISING MELANOMA RESEARCH WORLDWIDE THAT WILL IMPROVE THE OUTCOME FOR PATIENTS AND ALL WHO ARE AT RISK 0 0 6024337 5103877 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRAF") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO DEVELOP NOVEL DIAGNOSTIC AND THERAPEUTIC AVENUES RELEVANT TO PATHWAYS GOVERNING THE BEHAVIOR AND CLINICAL OUTCOME OF MELANOMA. MRAF CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT BIOMEDICAL RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRAF MAKES GRANTS TO DOMESTIC RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. MRAF ALSO MAKES GRANTS TO FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS AND MEDICAL RESEARCH ORGANIZATIONS. 6024337 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 1 14 0 0 0 0 0 0 0 0 0 0 0 0 X 15 14 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN NH NJ NM NY NC ND PA OR OK OH RI SC TN UT VA WA WI WV X X KAMYAB HASHEMI-NEJAD 3105704612 1250 FOURTH STREET SANTA MONICA CA 90401 DEBRA BLACK 20.00 X X 0 0 0 LEON BLACK 0.30 X 0 0 0 MARIA BELL 0.30 X 0 0 0 JASON FEDERICI 0.30 X 0 0 0 JAMI GERTZ 0.30 X 0 0 0 SUSAN HESS 0.30 X 0 0 0 MICHAEL KLOWDEN 0.30 X 0 438964 14202 CONNIE MACK 0.30 X 0 0 0 NANCY MARKS 0.30 X 0 0 0 MICHAEL MILKEN 0.30 X 0 0 0 RICHARD RESSLER 0.30 X 0 0 0 GREGORY SIMON 0.30 X 0 0 0 JONATHAN SIMONS 0.30 X 0 0 0 JONATHAN SOKOLOFF 0.30 X 0 0 0 ELIZABETH STANTON 0.30 X 0 0 0 WENDY SELIG 40.00 X 248639 0 15755 KAMYAB HASHEMI-NEJAD 10.00 X 0 149910 13580 LAUREN LEIMAN 40.00 X 147710 0 4051 LAURA BROCKWAY-LUNARDI 40.00 X 101314 0 9804 497663 588874 57392 3 0 1 0 0 21013477 50690 21013477 21414 21414 21034891 0 0 21414 4551711 4551711 552166 552166 264395 145417 58167 60811 378664 125765 95306 157593 35138 19660 7453 8025 32314 13523 7727 11064 15881 12995 373 2513 13875 13875 164482 142940 10532 11010 21452 14010 2235 5207 17275 10092 3357 3826 106163 82384 11533 12246 129125 70236 27891 30998 74786 37462 5891 31433 270303 238726 37 31540 3451 1845 738 868 9827 5405 2162 2260 STATE FILING FEES 11335 11185 150 CREDIT CARD PROCESSING 4095 4095 6656438 6024337 262557 369544 931130 3333239 5730021 6999554 9468362 20439692 17846 8274 12317 6208 5396 6109 555025 544375 16707780 31331243 59716 139051 25000 70000 19961 140636 104677 349687 X 6249741 9760006 10353362 21221550 16603103 30981556 16707780 31331243 14378453 0 X 0 1 1 X 0 X X X X 0 0 0 THE MILKEN INSTITUTE 954240775 7 1 1 1 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 7500 7500 6387119 6394619 469731 117433 0 0 592013 469731 1061744 1592616 4500 7500 12000 148003 117433 265436 398154 0 12317 6208 6109 6109 DUE TO MILKEN INSTITUTE/FASTERCURES 140636 140636 21034891 6656438 14378453 14378453 21034891 0 21034891 0 21034891 6656438 0 6656438 0 6656438 1 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 341666 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 160500 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 50000 0 0 0 0 0 0 552166 0 552166 NORTH AMERICA TEAM SCIENCE AWARD 300000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 75000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 35500 CHECK MIDDLE EAST AND NORTH AFRICA YOUNG INVESTIGATOR AWARD 50000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 50000 CHECK NORTH AMERICA YOUNG INVESTIGATOR AWARD 41666 CHECK 6 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: EACH PROPOSAL TO THE MRAF IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRAF'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRAF'S REQUEST FOR PROPOSALS, GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER A SCIENTIFIC PEER REVIEW BY THE GRC, THE MRAF BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AND AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRAF STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. AWARDEES PROVIDE MRAF WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRAF CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. 1 CHILDREN'S HOSPITAL BOSTON 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 300000 TEAM SCIENCE AWARD CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501(C)(3) 50000 PILOT AWARD COLD SPRING HARBOR LABORATORY 1 BUNGTOWN RD COLD SPRING HARBOR NY 11724 112013303 501(C)(3) 200000 TEAM SCIENCE AWARD COLUMBIA UNIVERSITY MEDICAL CENTER ICRC 402A 1130 ST NICHOLAS AVE NEW YORK NY 10032 135598093 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02115 042263040 501(C)(3) 250000 TEAM SCIENCE AWARD DUKE UNIVERSITY 2200 MAIN STREET DURHAM NC 27705 560532129 501(C)(3) 125000 TEAM SCIENCE AWARD FRED HUTCHINSON CANCER RESEARCH CENTER 100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 175000 TEAM SCIENCE AWARD H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 33334 TEAM SCIENCE AWARD HENRY FORD HEALTH SYSTEM 1 FORD PLACE 1D27 DETROIT MI 48202 381357020 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD JOHNS HOPKINS UNIVERSITY 1550 ORLEANS STREET BALTIMORE MD 21205 520595110 501(C)(3) 500000 TEAM SCIENCE AWARD MEMORIAL SLOAN-KETTERING CANCER INSTITUTE 1275 YORK AVENUE NEW YORK NY 10021 131924236 501(C)(3) 1166667 TEAM SCIENCE AWARDS, YOUNG INVESTIGATOR AWARDS, ACADEMIC-INDUSTRY PARTNERSHIP AWARD NEW YORK UNIVERSITY 550 FIRST AVE NEW YORK NY 10116 135562308 501(C)(3) 216667 TEAM SCIENCE AWARD, PILOT AWARD SAINT LOUIS UNIVERSITY 1100 S GRAND BLVD EDWARD A DOISY RESEARCH CENTER 8TH FLOOR ST LOUIS MO 63104 430654872 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 10901 N TORREY PINES ROAD LA JOLLA CA 92037 510197108 501(C)(3) 100000 ESTABLISHED INVESTIGATOR AWARD THE UNIVERSITY OF CHICAGO 5801 S ELLIS AVE CHICAGO IL 60637 362177139 501(C)(3) 125000 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF CALIFORNIA LOS ANGELES 11000 KINROSS AVE STE 102 LOS ANGELES CA 90095 956006143 PUBLIC UNIVERSITY 291667 TEAM SCIENCE AWARD, YOUNG INVESTIGATOR AWARD, PILOT AWARD UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN SOUTH RESEARCH PARK MC-685 1901 SOUTH FIRST STREET SUITE A CHAMPAIGN IL 61820 376000511 PUBLIC UNIVERSITY 100000 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 1374 HOUSTON TX 77030 174601118 PUBLIC UNIVERSITY 450000 YOUNG INVESTIGATOR AWARD, ESTABLISHED INVESTIGATOR AWARD, TEAM SCIENCE AWARD UNIVERSITY OF VIRGINIA PO BOX 800334 HOSPITAL WEST 6171 E BOX 800334 CHARLOTTESVILLE VA 22908 412097394 PUBLIC UNIVERSITY 794300 TEAM SCIENCE AWARDS, YOUNG INVESTIGATOR AWARD, ACADEMIC-INDUSTRY PARTNERSHIP AWARD WASHINGTON UNIVERSITY IN ST LOUIS 660 SOUTH EUCLID AVENUE ST LOUIS MO 63110 430653611 501(C)(3) 50000 ESTABLISHED INVESTIGATOR AWARD YALE UNIVERSITY 47 COLLEGE ST NEW HAVEN CT 06520 060646973 501(C)(3) 333334 TEAM SCIENCE AWARD 21 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: EACH PROPOSAL TO THE MRAF IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRAF'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRAF'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRAF BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRAF STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRAF-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRAF REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRAF TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRAF MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRAF WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRAF CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. X X X X X 0 0 0 0 0 0 0 0 0 MICHAEL KLOWDEN 0 438964 0 0 0 0 0 2450 0 11752 0 453166 0 0 WENDY SELIG 228639 0 20000 0 0 0 2450 0 13305 0 264394 0 0 0 KAMYAB HASHEMI-NEJAD 0 149910 0 0 0 0 0 1702 0 11878 0 163490 0 0 LAUREN LEIMAN 147710 0 0 0 0 0 0 0 4051 0 151761 0 0 0 PART I, LINE 3 ACCORDING TO THE MRAF BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRAF'S CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, THE BOARD USES COMPENSATION SURVEYS AND THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. X 2 50690 PROCEEDS (SEC SALES) 0 0 1 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS: PART I, COLUMN (B): THE "NUMBER OF CONTRIBUTORS REPORTED" ON SCHEDULE M ARE THE NUMBER OF SEPARATE CONTRIBUTIONS OF SECURITIES RECEIVED BY MRAF. W-2 EMPLOYEES FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE FOUNDATION ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN ON BEHALF OF MRAF. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK AND LEON BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 MRAF'S CEO AND TREASURER JOINTY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND FILES IT WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRAF BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRAF BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRAF CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, THE BOARD USES COMPENSATION SURVEYS AND THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRAF. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 MILKEN INSTITUTE J 127345 RENTAL EXPENSE PER SUBLEASE MILKEN INSTITUTE O 642061 CASH TRANSFERRED TO REIMBURSE EXP